- Home
- ASPSZ vs SCLXW Comparison
ASPSZ vs SCLXW Comparison
Compare ASPSZ & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPSZ
- SCLXW
- Stock Information
- Founded
- ASPSZ N/A
- SCLXW N/A
- Country
- ASPSZ Luxembourg
- SCLXW United States
- Employees
- ASPSZ 1160
- SCLXW 111
- Industry
- ASPSZ
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- ASPSZ
- SCLXW Health Care
- Exchange
- ASPSZ Nasdaq
- SCLXW Nasdaq
- Market Cap
- ASPSZ N/A
- SCLXW N/A
- IPO Year
- ASPSZ N/A
- SCLXW N/A
- Fundamental
- Price
- ASPSZ $0.64
- SCLXW $0.52
- Analyst Decision
- ASPSZ
- SCLXW
- Analyst Count
- ASPSZ 0
- SCLXW 0
- Target Price
- ASPSZ N/A
- SCLXW N/A
- AVG Volume (30 Days)
- ASPSZ N/A
- SCLXW 4.0K
- Earning Date
- ASPSZ N/A
- SCLXW 03-07-2025
- Dividend Yield
- ASPSZ N/A
- SCLXW N/A
- EPS Growth
- ASPSZ N/A
- SCLXW N/A
- EPS
- ASPSZ N/A
- SCLXW N/A
- Revenue
- ASPSZ N/A
- SCLXW $55,152,000.00
- Revenue This Year
- ASPSZ N/A
- SCLXW N/A
- Revenue Next Year
- ASPSZ N/A
- SCLXW N/A
- P/E Ratio
- ASPSZ N/A
- SCLXW N/A
- Revenue Growth
- ASPSZ N/A
- SCLXW 22.02
- 52 Week Low
- ASPSZ N/A
- SCLXW $0.18
- 52 Week High
- ASPSZ N/A
- SCLXW $0.18
- Technical
- Relative Strength Index (RSI)
- ASPSZ N/A
- SCLXW N/A
- Support Level
- ASPSZ N/A
- SCLXW N/A
- Resistance Level
- ASPSZ N/A
- SCLXW N/A
- Average True Range (ATR)
- ASPSZ 0.00
- SCLXW 0.00
- MACD
- ASPSZ 0.00
- SCLXW 0.00
- Stochastic Oscillator
- ASPSZ 0.00
- SCLXW 0.00
About ASPSZ Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.